Jennie Clarke is a Dermatology physician affiliated with University of Utah Hospital. OpenAlex indexes 67 publications with 616 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 N Medical Dr
Salt Lake City, UT 841320001
Telephone
801-581-2955Provider last certified this registry record 22 Apr 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Lilly USA, LLCProgram year20231 payment
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
25%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.9%Valacyclovir100%Part D≥26 patientsAzole Antifungal5.7%Fluconazole51%Ketoconazole49%Part D<11 patients+ 4 more classes in this area
Dermatology
24.5%Corticosteroid19.4%Triamcinolone Acetonide100%Part D≥97 patientsCalcineurin inhibitor1.8%Pimecrolimus100%Part D<11 patients+ 2 more classes in this area
Sensory organs
20.1%Corticosteroid20.1%Clobetasol Propionate66%Hydrocortisone23%Dexamethasone10%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The impact of allergen avoidance on oral lichen planus: A retrospective cohort-based comparison
Journal of the American Academy of Dermatology
2025 - The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study
Archives of Dermatological Research
2025 - 61355 Durability of Methotrexate, Mycophenolate, Azathioprine, and Cyclosporine in the Treatment of Oral Lichen Planus
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”